| Pharmaceutical active ingredients: |
| FinasterideTamsulosin Hydrochloride |
| Available forms, composition and doses of Urimax F: |
| Capsules, Modified Release; Oral; Finasteride 5 mg; Tamsulosin Hydrochloride 0.4 mg |
| Urimax F medical category: |
| Human:Drugs for bladder and prostate disorders |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D11AX10 - FinasterideG04CA02 - TamsulosinG04CB01 - Finasteride |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Cipla |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Urima | Sodium Citrate Dibasic | ACME Pharmaceuticals |
| Urimar-T | Hyoscyamine Sulfate; Methenamine; Methylene Blue; Salol; Sodium Phosphate Monobasic | Marnel Pharmaceuticals |
| Urimax | Ofloxacin | Bros |
| Urimax | Tamsulosin Hydrochloride | Cipla |
| Urimax | Hyoscyamine Sulfate; Methenamine; Methylene Blue; Salol; Sodium Phosphate Monobasic | Integrity, United States; Xanodyne Pharmaceuticals |
| Urimax-D | Dutasteride; Tamsulosin Hydrochloride | Cipla |
| Urimet SPF 15 | Sunscreen; Urea | Roemmers-Klinos |
| Urimeth | Methionine | Unidentified Pharmaceutical Company |
| Urimiodin | Trisodium Uridine Triphosphate Anhydrous; Vitamin B12 (Cyanocobalamin) | Francia Farmaceutici Industria Farmaco Biologica |
| Urinary Hebin | Follicle Stimulating Hormone | Unidentified Pharmaceutical Company |